The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
International Classification of Diseases
Jones, F. A. (1978) · Gut · doi:10.1136/gut.19.12.1175 · Cited by 2,911
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
International Classification of Diseases
Peery, M. L. (2014) · Encyclopedia of Special Education · doi:10.1002/9781118660584.ese1248 · Cited by 979
Stolt, P., Bengtsson, C., Nordmark, B., Lindblad, S., Lundberg, I., Klareskog, L., & Alfredsson, L. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.9.835 · Cited by 648
Self-citationWolfe, F., & Michaud, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20311 · Cited by 644
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H.-O., Hacker, D. G., Hoover, R., & Fraumeni, J. F. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.307 · Cited by 581
Self-citationMattsson, B., & Wallgren, A. (1984) · Acta Radiologica: Oncology · doi:10.3109/02841868409136026 · Cited by 559
Geborek, P., Bladström, A., Turesson, C., Gulfe, A., Petersson, I. F., Saxne, T., Olsson, H., & Jacobsson, L. T. H. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030528 · Cited by 427
Self-citationRheumatoid arthritis and cancer risk
Mellemkjær, L., Linet, M. S., Gridley, G., Frisch, M., Møller, H., & Olsen, J. H. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00210-9 · Cited by 383
Risk of malignancy among patients with rheumatic conditions
Thomas, E., Brewster, D. H., Black, R. J., & Macfarlane, G. J. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001101)88:3<497::aid-ijc27>3.0.co;2-j · Cited by 332
Terry, M. B. (2004) · JAMA · doi:10.1001/jama.291.20.2433 · Cited by 271
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study
Sørensen, H. T., Friis, S., Nørgård, B., Mellemkjær, L., Blot, W. J., McLaughlin, J. K., Ekbom, A., & Baron, J. A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600945 · Cited by 221
The person-number systems of Sweden, Norway, Denmark, and Israel.
As, L., Lundeborg, S., Gs, L., Thygesen, L. C., & Huebner, J. (1980) · PubMed · Cited by 206
Rheumatoid arthritis and the risk of malignancy
Cibere, J., Sibley, J., & Haga, M. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400906 · Cited by 161
Review of the in vitro spectrum of activity of imipenem
Jones, R. N. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90098-1 · Cited by 121
Neoplasms of the immune system in rheumatoid arthritis
Symmons, D. P. M. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90241-4 · Cited by 110
Symmons, D. P. M., & Silman, A. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20312 · Cited by 60
Clinical trials in rheumatic diseases: designs and limitations
Pincus, T., & Sokka, T. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.08.002 · Cited by 30
Cited by
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Inflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184
The safety and side effects of monoclonal antibodies
Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A., & George, A. J. T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3003 · Cited by 1,144
Klareskog, L., Catrina, A. I., & Paget, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60008-8 · Cited by 787
Self-citationUpdated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Metadata
- Authors
- Askling, J., Fored, C. M., Brandt, L., Baecklund, E., Bertilsson, L., Feltelius, N., Cöster, L., Geborek, P., Jacobsson, L. T., Lindblad, S., Lysholm, J., Rantapää-Dahlqvist, S., Saxne, T., & Klareskog, L.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 64
- Issue
- 10
- Pages
- 1421-1426
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2104388056
- Cited by
- 377
- References
- 19
- FWCI
- 17.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.